Literature DB >> 11651693

IRBs and pharmaceutical company funding of research.

Michael S Jellinek, Robert J Levine.   

Abstract

Keywords:  Biomedical and Behavioral Research; Legal Approach; National Commission for the Protection of Human Subjects

Mesh：

Year:  1982        PMID： 11651693

Source DB:  PubMed          Journal:  IRB        ISSN： 0193-7758


× No keyword cloud information.
  6 in total

1.  Ethical issues and clinical trials.

Authors:  D S Shimm; R G Spece
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

2.  New quality and quantity indices in science (NewQIS): the study protocol of an international project.

Authors:  Beatrix Groneberg-Kloft; Tanja C Fischer; David Quarcoo; Cristian Scutaru
Journal:  J Occup Med Toxicol       Date:  2009-06-26       Impact factor: 2.646

3.  Potential research participants' views regarding researcher and institutional financial conflicts of interest.

Authors:  S Y H Kim; R W Millard; P Nisbet; C Cox; E D Caine
Journal:  J Med Ethics       Date:  2004-02       Impact factor: 2.903

4.  Analysis of research output parameters: density equalizing mapping and citation trend analysis.

Authors:  Beatrix Groneberg-Kloft; Cristian Scutaru; Axel Fischer; Tobias Welte; Carolin Kreiter; David Quarcoo
Journal:  BMC Health Serv Res       Date:  2009-01-27       Impact factor: 2.655

5.  Institutional operating figures in basic and applied sciences: scientometric analysis of quantitative output benchmarking.

Authors:  Beatrix Groneberg-Kloft; Cristian Scutaru; Carolin Kreiter; Silvana Kölzow; Axel Fischer; David Quarcoo
Journal:  Health Res Policy Syst       Date:  2008-06-13

6.  Interfield dysbalances in research input and output benchmarking: visualisation by density equalizing procedures.

Authors:  Beatrix Groneberg-Kloft; Carolin Kreiter; Tobias Welte; Axel Fischer; David Quarcoo; Cristian Scutaru
Journal:  Int J Health Geogr       Date:  2008-08-25       Impact factor: 3.918
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.